Drug advertisements that scare
Despite larger health threats consuming the nation this year, pharma did not let up on their fear-mongering advertisements. Check out a few of the scariest-- if you dare! More
Is the price of remdesivir too high or too low?
Experts weigh in on the recently revealed price of Covid-19 drug remdesivir. More
Remdesivir report sparks more debate on drug price value
How much should remdesivir cost? This question puts two drug-value organizations at odds. More
Are high drug prices buying us the most effective treatments?
The pharmaceutical industry often justifies high drug prices by claiming that they create more innovation, but two recent studies find that drug costs and clinical benefit are often not related. More
What we lose by promoting unproven Covid-19 remedies
Breaking down the flawed logic of "What do we have to lose?" when it comes to untested Covid-19 treatments. More
The true cost of “free” samples
Many physicians see drug samples as a benefit, because they can give pills to patients who may not be able to afford the medication otherwise. But are these "free" samples really free? More
New Alzheimer’s drug: Game-changing or underwhelming?
When it comes to dementia and Alzheimer's Disease, it appears that anxiety about cognitive decline is driving treatment decisions, rather than evidence. More
More doctors than ever are pharma-made millionaires
Is sunshine really the best disinfectant? Or do we need much more than transparency when it comes to financial conflicts of interest? More
This year’s spoooooookiest pharma ads
It's a Lown Institute tradition to highlight pharma's fear-mongering on Halloween, and this year is no exception. More
Is this $2 million gene therapy drug priced “fairly”?
The approval of a new gene therapy to treat spinal muscular atrophy has created a hot debate in the health policy world about whether or not the drug's $2.1 million price tag is too expensive or a fair price. More